Navigation Links
Georgia State researcher gets $3.4 million grant to develop vaccine technology against flu, RSV
Date:1/30/2013

ATLANTA Sang-Moo Kang, associate professor at Georgia State University's Center for Inflammation, Immunity and Infection, has received a federal five-year, $3.4 million grant to bolster research that will lead to better flu vaccines and vaccines against respiratory syncytial virus (RSV), a disease for which there is no immunization.

The grant from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases will aid Kang's research in developing a virus-like particle, or VLP, vaccine technology.

VLPs mimic viruses, but are non-infectious, which allows for safer vaccines, especially for young children, elderly people and patients whose immune systems are compromised. VLPs trigger the immune system to respond, leading to immunity in the same way that regular vaccines made with whole viruses act.

"VLPs are a result of new technology using recombinant genetic engineering," Kang said. "VLP technology can manipulate pathogens in a safe way so that we can design a vaccine mimicking the shape and structure of a virus.

"A VLP is an empty particle without the genetic information of a pathogen, thus highlighting its safety."

The potential of this research could lead to not only better vaccines for influenza, which is potentially deadly in some patients and which has led to deaths during this year's flu season, but also RSV.

RSV is a respiratory virus that infects the lungs and breathing passages. Most healthy people can recover from RSV infection in one to two weeks, but infections can be severe in young children, infants and older adults.

According to the Centers for Disease Control and Prevention, about 75,000 to 125,000 hospitalizations related to RSV occur among children under one year old, and RSV infection results in about 1.5 million outpatient medical visits among children under the age of five.

Kang's lab will test VLP technology and ways to deliver the vac
'/>"/>

Contact: Jeremy Craig
404-413-1357
Georgia State University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Georgia Tech launches HomeLab to help companies evaluate home health technologies
2. Mary Rieser of Narconon Georgia Speaks Out For United Nations International Day Against Drug Abuse
3. NIH awards Georgia malaria research consortium up to $19.4 million contract
4. Georgia Partnership for TeleHealth, Inc. and Georgia's Lt. Governor Casey Cagle's Office Hosted the 2nd Annual School Based Health Center Summit on November 9, 2012
5. Piedmont Orthopaedic Complex is First to Provide Baseline Brain Function Test for Athletes in Central Georgia
6. Way to make one-way flu vaccine discovered by Georgia State researcher
7. Metro Atlanta ServiceMasters Team Up to Offer Higher Quality of Water Damage, Mold Removal, Carpet Cleaning and Fire Damage Services to Customers in North Georgia
8. Childcare Network Announces Acquisition of 22 Learning Centers from Children’s Friend of Georgia
9. Halcyon Completes First Acquisition in South Georgia
10. ShapeMed - http://www.ShapeMed.com - Offers Testosterone Screening for Men in Georgia
11. New target to stop cancers spread discovered by Georgia State scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Recent tragedies including the Oklahoma ... shooting in Newtown, Connecticut all resulted in serious, ... Emergency medical practitioners train to respond to both ... Services for Children (EMSC) Program specifically provides instruction, ... youngest patients. It is estimated 30 million children ...
(Date:5/22/2013)... 2013 HR Strategies recently participated in ... Gwinnett County Fairgrounds, on Friday May 10, 2013. For ... surpassed expectations; raising over $6,300 for cancer research. ... event, donating the first $3,000 for Bronze Level Sponsorship. ... internal staff to match the company’s contribution of $3,000; ...
(Date:5/22/2013)... By Alan Mozes HealthDay Reporter , , WEDNESDAY, ... the number of American children who die each year ... new research reveals. And increasing numbers of children are ... pool of potential organ donors expanded to include not ... with a "circulatory determination of death." But it,s ...
(Date:5/22/2013)... of internal medicine residents at Massachusetts General Hospital (MGH) ... found that more than half rated the training they ... as fair or poor. Significant numbers felt unprepared to ... of practicing physicians. In response to the findings, recently ... the MGH has increased residents, training in addiction medicine. ...
(Date:5/22/2013)... provides neurobiological evidence for dysfunction in the neural ... which may have implications for the risk relationship ... consistently identified as a risk factor for depression," ... professor of psychiatry at the University of Pittsburgh ... underlying emotion regulation may be involved in the ...
Breaking Medicine News(10 mins):Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Study shows that insomnia may cause dysfunction in emotional brain circuitry 2
... BOARD,S INTERESTS ARE NOT ALIGNED WITH STOCKHOLDERSADVOCAT BOARD NEEDS ... Calif., May 19 Bristol Investment Fund, Ltd. ("Bristol") ... the stockholders of Advocat, Inc. (the "Company") (Nasdaq: ... highly qualified and independent director nominees, Paul Kessler and ...
... microsite (www.meettheburns.com) targets first time athlete,s foot sufferers ... Schering-Plough Corporation (NYSE: SGP ... an antifungal spray for the treatment of athlete,s ... liquid spray and deodorant powder spray.(Photo: ...
... Sustainable Healthcare CHICAGO, May 19 Practice ... to environmentally responsible healthcare, has announced its ... competitive awards are given to institutions within ... reduce the facility,s environmental footprint.Fletcher Allen Health ...
... differ across continents, posing challenges to drug launches. ... regulatory environment of the European Union (EU) and ... less price controlled markets witness quicker launches, while ... industry, along with regulatory agencies, has been working ...
... 2009 The International Diabetes Federation (IDF), International ... (WHF) today issued a joint statement that calls ... epidemic of non-communicable diseases (NCDs), responsible for 35 ... substantial increase in funding for NCDs and greater ...
... in the Los Angeles , California area will be ... describe a revolutionary laser liposuction procedure. Dr. ... Center is one of the first surgeons on ... laser liposuction technique -- that not only melts fat, ...
Cached Medicine News:Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 3Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 4Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 5Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 6Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 7Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 8Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 9Health News:Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males 2Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 2Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 3Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 4Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 5Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 6Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 7Health News:Practice Greenhealth Announces Winners of 2009 Environmental Excellence Awards 8Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 2Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 3Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 4Health News:Leading NGOs call for international action to combat epidemic of noncommunicable diseases 2Health News:Leading NGOs call for international action to combat epidemic of noncommunicable diseases 3Health News:Leading NGOs call for international action to combat epidemic of noncommunicable diseases 4Health News:Los Angeles Cosmetic Plastic Surgeon Dr. Christine Petti and Smartlipo Featured on Upcoming Episode of The Doctors 2Health News:Los Angeles Cosmetic Plastic Surgeon Dr. Christine Petti and Smartlipo Featured on Upcoming Episode of The Doctors 3Health News:Los Angeles Cosmetic Plastic Surgeon Dr. Christine Petti and Smartlipo Featured on Upcoming Episode of The Doctors 4
(Date:5/22/2013)... 22, 2013  The Leukemia & Lymphoma Society (LLS) ... Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, ... a Phase I clinical trial for a novel fusion ... many patients with indolent lymphomas who do not respond ... protein, IGN002, is a new class of biotherapeutics produced ...
(Date:5/22/2013)... YORK , May 22, 2013  For the 3% ... excessive sweating is often embarrassing, uncomfortable, anxiety-inducing and disabling.  ... diagnosed or treated for their symptoms, hyperhidrosis is a ... treatment solution available called Precision TX™. Dr. ... JUVA Skin & Laser Center in New ...
(Date:5/22/2013)... , May 22, 2013  Modern Medical announced ... (ODM).  Launched in November 2012 in a test ... program to stop the rising opioid abuse in ... customized program designed to protect employees, physicians and ... the necessary balance to provide pain relief for ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Is There Finally A Way To Stop Severe Excessive Sweating? 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2
... governmental markets still depressed, Allied Healthcare Products (Nasdaq: AHPI ... year 2011 and improvement in its year-over-year performance. ... 1 cent per basic and diluted share, compared to $22,000, or ... first two quarters of the fiscal year, net income was about ...
... Feb. 8, 2011 Actavis Group, an international generic ... from the US Food & Drug Administration to market ... will commence shortly.   Pantoprazole Sodium Delayed-Release ... 20mg and 40mg by Pfizer, had US sales of ...
Cached Medicine Technology:Allied Healthcare Products Reports Modest Profit for Quarter 2Allied Healthcare Products Reports Modest Profit for Quarter 3Allied Healthcare Products Reports Modest Profit for Quarter 4Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S. 2
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t...
... The SYNCHRON CX4 Delta Specialty / ... access analyzer that can consolidate Drugs ... testing, such as thyroid, HbA1c and ... CX4 Delta offers a level of ...
Inquire...
... Analyzer is a high precision optical system ... of the anterior eye segment, based on ... a Placido Disk. , GALILEI combines the ... high accuracy curvature data, while Scheimpflug imaging ...
Medicine Products: